Background illustration for clinical trials search

Eczema Clinical Trials

Browse 98 eczema clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults

for
Pain, Tolerance, Oral vs Vaporized THC, Abuse Liability
Location: West Haven CT
Sponsor: Yale University

Sex: All

Age: 65+

Code: NCT05906511

Early_phase1, Recruiting

Improving the Care of Incontinence-Associated Dermatitis (IAD) Using a Beta-Glucan Cream as a Hydrating and Soothing Agent

for
Fecal Incontinence, Urinary Incontinence, Diaper Rash,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT07524439

Recruiting

Behavioral Pharmacology of Orally Administered THC and D-limonene

for
Subjective Drug Effects, THC, D-limonene
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 21 - 55

Code: NCT06378957

Phase1, Recruiting

The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis

for
Dermatitis, Atopic, Pruritus
Location: Boynton Beach FL
Sponsor: Nexgen Dermatologics, Inc.

Sex: All

Age: 12 - 70+

Code: NCT06488742

Recruiting

Systemic Therapies for Pediatric Atopic Dermatitis

for
Dermatitis, Atopic
Location: Chicago IL, San Diego CA, San Francisco CA
Sponsor: Rady Children's Hospital, San Diego

Sex: All

Age: 2 - 17

Code: NCT01447381

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis

for
Milk and/or Peanut Allergy
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 21

Code: NCT03835767

Phase2, Recruiting
Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for
Atopic Dermatitis
Location: Quincy MA, Boston MA, New Haven CT, Lebanon NH, Quebec,
Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting
Featured

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

for
Hidradenitis Suppurativa, Atopic Dermatitis
Location: Ann Arbor MI, Sacramento CA
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06524635

Phase2, Recruiting

Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging.

for
Eczema, Atopic Dermatitis
Location: New York NY
Sponsor: OptiSkin Medical

Sex: All

Age: 18+

Code: NCT05265234

Recruiting

A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis

for
Moderate to Severe Atopic Dermatitis
Location: Philadelphia PA, Boardman OH, Plainfield IN,
Sponsor: Sitryx Therapeutics Ltd

Sex: All

Age: 18 - 65

Code: NCT07558668

Phase1, Recruiting

Flourish: Exploring the Early Infant Gut Microbiome

for
Microbiota, Gut Microbiome, Eczema, Microbiome
Location: Austin TX
Sponsor: Seeding Inc

Sex: All

Age: 0

Code: NCT07333482

Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: The Bronx NY, Robbinsville NJ, Tamarac FL, Savannah GA,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07711418

Phase3, Recruiting

A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis

for
Moderate-to-Severe Atopic Dermatitis
Location: New York NY, Clifton NJ, Wilmington NC, Boca Raton FL,
Sponsor: Nektar Therapeutics

Sex: All

Age: 12+

Code: NCT07690371

Phase3, Recruiting

Virtual Reality for Pain Management During Dupilumab Injection

for
Atopic Dermatitis, Pain, Anxiety
Location: Montreal
Sponsor: St. Justine's Hospital

Sex: All

Age: 6 - 17

Code: NCT06182436

Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Portsmouth NH, Brighton MA, Brooklyn NY, Montreal,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: Quincy MA, Johnston RI, Ottawa, Boca Raton FL,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase2, Recruiting

A Prospective Sample Collection Study Using Non-invasive Methods to Investigate Biomarkers in AD Patients

for
Atopic Dermatitis
Location: New York NY, Rochester NY
Sponsor: DermTech

Sex: All

Age: 1+

Code: NCT04699695

Recruiting

Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic Dermatitis

for
Atopic Dermatitis
Location: Philadelphia PA
Sponsor: Realm Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT03351777

Phase2, Recruiting